The Self-Sampling Pilot Study
NCT07085845 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50
Last updated 2026-01-27
Summary
The investigators will test the cytological performance of a nylon-flocked swab at two insertion depths in the anus, 3 cm and 5 cm, to determine which insertion depth is better at collecting cells from the squamocolumnar junction (SCJ), an anatomic site that is particularly vulnerable to carcinogenic transformation. The investigators hypothesize that the 5 cm insertion will result in a higher quality specimen with cells from the SCJ. However, the deeper swab insertion may affect end user acceptability without increasing adequacy or quality.
Conditions
- Squamous Cell Carcinoma of the Anus
Interventions
- OTHER
-
Inserting a swab 5 cm into the anus during self-sampling
The swab will be inserted into the anus by the lay individual. The individual will insert the swab to a depth of 5 cm to collect anal exfoliated cells.
- OTHER
-
Self-sampling with a swab by inserting the swab 3 cm into the anus.
The swab will be inserted into the anus by the lay individual. The individual will insert the swab to a depth of 3 cm to collect anal exfoliated cells.
Sponsors & Collaborators
-
Medical College of Wisconsin
lead OTHER
Principal Investigators
-
Alan Nyitray, PhD · Medical College of Wisconsin
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SCREENING
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 35 Years
- Sex
- MALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2025-07-31
- Primary Completion
- 2025-09-12
- Completion
- 2025-09-12
Countries
- United States
Study Locations
More Related Trials
-
A Study to Test BI 754091 Alone or in Combination With BI 836880 in People Who Have Advanced Anal Cancer
NCT04499352 ·Status: WITHDRAWN ·Phase: PHASE2
-
A Phase 2 Study of Axalimogene Filolisbac (ADXS11-001) in Participants With Carcinoma of the Anorectal Canal
NCT02399813 ·Status: COMPLETED ·Phase: PHASE2
-
Celecoxib in Treating Patients With Early-Stage Rectal Cancer
NCT00608595 ·Status: TERMINATED ·Phase: NA
-
Savolitinib in Treating Patients With MET Amplified Metastatic or Unresectable Colorectal Cancer
NCT03592641 ·Status: TERMINATED ·Phase: PHASE2
-
A Multicenter Study of Active Specific Immunotherapy With OncoVax® in Patients With Stage II Colon Cancer
NCT02448173 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Lenvatinib and Pembrolizumab to Treat Patients With Anal or Rectum Cancer That Has Gotten Worse After Initial Treatment
NCT06669572 ·Status: RECRUITING ·Phase: PHASE2
-
Phase II Study of Irinotecan,Oxaliplatin Plus TS-1 in Untreated Metastatic Colorectal Cancer
NCT00506571 ·Status: UNKNOWN ·Phase: PHASE2
-
High Dose Vitamin C Intravenous Infusion in Patients With Resectable or Metastatic Solid Tumor Malignancies
NCT03146962 ·Status: COMPLETED ·Phase: PHASE2
-
Chloroquinoxaline Sulfonamide in Treating Patients With Stage IV Colorectal Cancer
NCT00005864 ·Status: COMPLETED ·Phase: PHASE2
-
Development of a Health-Related Symptom Index for Participants With and Either Treated or Monitored for Anal High-Grade Squamous Intraepithelial Lesions
NCT04276935 ·Status: COMPLETED
-
Nivolumab With or Without Ipilimumab in Treating Patients With Refractory Metastatic Anal Canal Cancer
NCT02314169 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Neoadjuvant Study of Recombinant Vaccinia Virus to Treat Metastatic Colorectal Carcinoma in Patients Undergoing Complete Resection of Liver Tumors
NCT01329809 ·Status: TERMINATED ·Phase: PHASE2
-
Standard of Care Alone or in Combination With Ad-CEA Vaccine and Avelumab in People With Previously Untreated Metastatic Colorectal Cancer QUILT-2.004
NCT03050814 ·Status: TERMINATED ·Phase: PHASE2
-
Nimotuzumab With Radiotherapy in the Treatment of Anal Canal Cancers
NCT01382745 ·Status: TERMINATED ·Phase: PHASE2
-
Evaluating the Safety and Efficacy of SB Injection in Patients With Advanced or Metastatic Colorectal Cancer
NCT01305980 ·Status: UNKNOWN ·Phase: PHASE2
-
A Study to Test Different Doses of BI 765049 in People With Advanced Cancer of the Colon, Rectum, Stomach, or Pancreas
NCT06882746 ·Status: RECRUITING ·Phase: PHASE1
-
Phase II Clinical Study to Evaluate the Efficacy and Safety of HLX07+HLX10 +mFOLFOX6 or HLX07 Monotherapy in Patients With mCRC
NCT05239650 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
A Study of JNJ-95437446 in Participants With Advanced-Stage Solid Tumors
NCT07107230 ·Status: RECRUITING ·Phase: PHASE1
-
A Study Evaluating TAS-102 Plus Nivolumab in Patients With MSS CRC
NCT02860546 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Safety and Efficacy of Selinexor With or Without Pembrolizumab Versus Standard of Care in Previously Treated Metastatic Colorectal Cancer With RAS Mutations
NCT04854434 ·Status: TERMINATED ·Phase: PHASE2
-
A Phase II Study to Assess Acute Toxicity and Quality of Life of Patients With Carcinoma of the Anal Canal Receiving Chemotherapy and Radiation Using Helical Tomotherapy
NCT00754078 ·Status: UNKNOWN ·Phase: PHASE2
-
The Safety and Efficacy Test of Immuncell-LC to Treat Refractory Metastatic Colorectal Cancer
NCT03220984 ·Status: UNKNOWN ·Phase: PHASE2
-
The Phase-2 CCR5-targeting Leronlimab With Oral Chemotherapy and VEGF-inhibitor Enriched Regimen Trial (CLOVER)
NCT06699836 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
A Study of INCMGA00012 in Squamous Carcinoma of the Anal Canal Following Platinum-Based Chemotherapy (POD1UM-202)
NCT03597295 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase II Study of SHR-8068 Injection in Combination With Anti-tumor Therapies in Colorectal Cancer
NCT07071714 ·Status: RECRUITING ·Phase: PHASE2